Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
PORCINE FOLLICLE STIMULATING HORMONE
Vetoquinol UK Limited
QG03GA90
PORCINE FOLLICLE STIMULATING HORMONE
700 International Unit
Pdr+Solv for Soln for Inj
POM
Bovine
Follicle stimulating hormone-pituitary
Hormone
Authorised
2015-11-06
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Folltropin 700 IU Powder and Solvent for solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Powder vial contains: ACTIVE SUBSTANCE Follicle Stimulating Hormone (FSH) 700 IU* *(established by WHO Expert Committee on Biological Standardisation in 1986) Solvent vial contains: EXCIPIENTS Benzyl alcohol 360 mg One ml of reconstituted solution contains: ACTIVE SUBSTANCE: Follicle Stimulating Hormone (FSH) 35 IU EXCIPIENTS Benzyl alcohol 18 mg For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Powder and solvent for solution for injection Powder: Freeze dried off-white powder Solvent: Clear, colourless solution Reconstituted solution: Clear, slightly pink solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (reproductively mature females). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES To induce superovulation in reproductively mature heifers or cows. 4.3 CONTRAINDICATIONS Do not use in known cases of hypersensitivity to the active ingredient. Do not use in males and reproductively immature female cattle. Do not use in pregnant cattle. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 14/06/2016_ _CRN 7023435_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS The product should only be used in clinically healthy cows, which are cycling normally. There is a wide range in response to superovulation between animals. There may be a small proportion of non-responders in any group treated. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Care should Read the complete document